Belimumab add-on therapy eased fatigue and disease activity in Saudi lupus cohort over 12 months
A prospective 12-month cohort study of 36 Saudi patients with lupus found that belimumab add-on therapy was associated with significant ...
A prospective 12-month cohort study of 36 Saudi patients with lupus found that belimumab add-on therapy was associated with significant ...
A network meta-analysis of 15 randomized trials ranks telitacicept highest for SRI-4 response in lupus but links it to more ...
A pooled pharmacokinetic analysis found that a simplified two-weight-band 200-mg subcutaneous belimumab regimen would match the exposure and predicted response ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.